CIRM Funded Clinical Trials
A Phase 2b, Randomized, Assessor-Masked Clinical Trial to Assess the Safety and Efficacy of the CPCB-RPE1 Implant in Subjects with Geographic Atrophy
Disease Area:
Age-related macular degeneration
Trial Sponsor:
Regenerative Patch Technologies LLC
Trial Stage:
Phase 2
Trial Status:
Launching
Targeted Enrollment:
N/A
